Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ORGO

Organogenesis Holdings Inc.

CIK 0001661181 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$1.80
↓ 0.04 (-2.17%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$231.62M
P/E Ratio
-2.75
EPS
0.16
Dividend Yield
Not covered
52W Position
5%
Beta
1.30

Valuation multiples

Fwd P/E
12.67
PEG
Not covered
P/B
1.56
P/S
0.51
EV/Revenue
0.41
ROE
-56.8%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 5%
$1.54$7.08

Latest Financials

2025-12-31 FY
Revenue
$564.17M
Net Income
$37.03M
Total Assets
$598.73M
Free Cash Flow
-$24.46M

Recent news